What happens when an Army Green Beret becomes a nurse and spends 25 years working in the E.R.? more...
Our innovatiive catheter, Venaglide, incorporates three new fully passive safety features into the product to improve catheterization efficacy. more...
Coming soon! The Venaglide Safety IV Catheter is not FDA cleared and is not available for sale at this time. Check back later for updates and contact us for more information.
I-V Access Technology designed its intravenous (IV) catheter, Venaglide, with fully passive safety features to address the needs of both healthcare workers and patients.
To successfully access veins, even small, fragile or tramaticly stressed ones, Venaglide utilizes a smaller gauge needle than typical, then uses a dilator to expand the lumen, allowing the easy introduction of the catheter into the vein.
Once the vein is accessed, fully passive, automatic needle retraction withdraws the needle tip safely within the dilator, allowing the catheter to be positioned in the vein with less risk of vascular damage which could otherwise lead to hematoma or infiltration.
With the catheter in position, the needle and dilator are withdrawn, and a one way, blood control valve reduces the risk of blood leakage, until the IV connector is attached to the catheter.
After removal from the catheter, the needle tip is safely shielded inside the dilator. The dilator provides fully passive protection from accidental needlesticks until needle and dilator are properly disposed of.
One of our founders, a former Army Green Beret who spent twenty-five years as an E.R. nurse, invented an innovative catheter with distinctive, fully passive features designed for clinician performance and patient saftety.
I-V Access Technology, inc. is a private medical device company committed to bringing this breakthrough catheter, Venaglide, to the market to transform the the venous access experience for patients and clinicians.
The story of our company began in 2011, when we raised our first round of funding. Today, we are focused on the FDA submission and clearance process, and plan to announce our commercial launch soon.
Our mission is to create a new standard in venous access products.
Jim joined I-V Access Technology in 2011 as interim CEO. He previously was the Managing Director at Tramway Venture Partners in Santa Barbara, CA.. Prior to that he was C.O.O of, Linac Systems, leading the commercialization of the worlds’ most compact linear accelerator. He also spent seven years with Technology Ventures Corporation, helping build technology companies along side investors and strategic partners. Before that he was a sales and marketing executive in the food industry for two Fortune 500 companies: Hormel Foods Corporation and Foodbrands/IBP. He has a BA from University of the Pacific and an MA from the University of Minnesota.
Peg joined the IV-Access Technology team in 2016, serving as Director of Sales and Marketing. She has over fifteen years of experience in direct sales and marketing in the Vascular Access segment of medical devices. Peg started her sales career with Johnson & Johnson, earning promotions to Executive Sales Representative, Strategic Account Manager, Division Sales Manager and U.S. Marketing Manager. She has recently worked for Teleflex, Inc. and B. Braun Medical. Peg graduated from the University of Hawaii with a degree in Business.
Brian serves as President of I-V Access Technology Inc, continuing the legacy of his father’s creation. He co-founded this company with a heart to advocate for improved healthcare for patients by advocating for new technologies. Brian is also a nurse with over 10 years of experience, working in various hospital and correctional settings, including the emergency room, intensive care unit, medical surgical and telemetry floor. Previously he owned and operated a clothing store along with an online medical scrubs design and distribution company. He attended Pepperdine University.
Robert Crockett received his Ph.D. from University of Arizona in Materials Science and Engineering. He holds an M.B.A. from Pepperdine University and a B.S. in Mechanical Engineering from University of California, Berkeley. He is currently a Professor in Biomedical Engineering and the Director of the General Engineering Program at California Polytechnic State University, San Luis Obispo. Dr. Crockett is a specialist in technology development and commercialization of advanced materials and medical devices. Prior to joining Cal Poly, he was founder and President of Xeragen, Inc., a San Luis Obispo-based biotechnology startup company. In addition to his academic work in Innovation & Entrepreneurship, Dr. Crockett is currently involved in four other medical technology-based startup companies.
After attending Cal Poly State University, Michael began his career in technology with county government. In 1980 he founded Computer And Software Enterprises, Inc. (CASE) which developed proprietary MIS systems for large companies. For the last 30 years CASE's focus has been in Banking and Financial Services and is recognized as the premier software solution in the asset based lending industry. Mike sold that company in 2015. He is also a Co-founder and board member of SLO Seed Ventures,. an Angel Group which finances early stage companies. He serves on the board and is an investor in LeftLane Sports.
Exciting news and press releases coming soon!
I-V Access Technology, Inc.
P.O. Box 3437
San Luis Obispo, CA 93403